Pharma


  • A large group of dosing pens for subcutaneous injection of anti-obesity medication piled in a heap.
    Image attribution tooltip
    aprott via Getty Images
    Image attribution tooltip

    Beyond the drug: Closing the knowledge gap for injectable diabetes meds

    As the diabetes and weight loss market booms, more collaboration between pharma and medtech could help patients get the most out of injectable drugs. 

    By April 22, 2025
  • A picture of a man tied to a COVID-19 virus
    Image attribution tooltip
    wildpixel via Getty Images
    Image attribution tooltip

    Genetic breakthroughs could point pharma to a long COVID drug

    The discoveries also hold potential benefits for patients with other conditions, such as chronic fatigue syndrome.

    By Kelly Bilodeau • April 22, 2025
  • clinical trial diversity Explore the Trendline
    Image attribution tooltip
    Stock via Getty Images
    Image attribution tooltip
    Trendline

    Clinical trial diversity

    As pharma wises up to the fact that the current playbook for improving clinical trial diversity has yet to make a meaningful impact, the quest is on to refine that approach.

    By PharmaVoice staff
  • A Novo Nordisk sign is seen on the side of a building.
    Image attribution tooltip
    hapabapa via Getty Images
    Image attribution tooltip

    Can anything threaten Novo and Lilly’s obesity market dominance?

    Five GLP-1 products will collectively bring in $470 billion by 2030, and the market leaders are working to hold back competition.

    By April 21, 2025
  • beaker shelved
    Image attribution tooltip
    Stock via Getty Images
    Image attribution tooltip

    How a scrapped Pfizer drug became a winner for SpringWorks

    SpringWorks Therapeutics and the Children’s Tumor Foundation salvaged a shelved asset for neurofibromatosis and got it over the regulatory finish line.

    By Alexandra Pecci • April 21, 2025
  • layoffs
    Image attribution tooltip
    Anna Moneymaker via Getty Images
    Image attribution tooltip
    Deep Dive

    HHS layoffs may be illegal, legal experts say

    The federal health department sidestepped normal procedures as it laid off 10,000 employees, according to sources. One union has already filed an internal complaint, while at least two law firms are exploring suits.

    By Rebecca Pifer • April 17, 2025
  • A sign spelling Novartis hangs on the side of a building.
    Image attribution tooltip
    Sedat Suna via Getty Images
    Image attribution tooltip

    Novartis scores NFL deal to tackle health outcomes

    The non-traditional marketing approach comes amid a potential crackdown on TV drug ads. 

    By April 17, 2025
  • Downtown Raleigh, North Carolina, skyline with a sunset
    Image attribution tooltip
    Stock via Getty Images
    Image attribution tooltip

    Amid an onshoring push, Raleigh is poised to be pharma’s next manufacturing hub

    Lower operating costs and a supply of high-skilled workers are helping the North Carolina region pull in billions of pharma manufacturing investments. 

    By Alexandra Pecci • April 16, 2025
  • UnitedHealthCare sign
    Image attribution tooltip
    Stephen Maturen via Getty Images
    Image attribution tooltip

    The fallout from UnitedHealth’s CEO slaying

    Brian Thompson’s murder has raised questions about the cost of U.S. healthcare, embroiling insurers, drugmakers and PBMs in a battle for the future of the industry.

    By PharmaVoice staff • April 15, 2025
  • Tariff pharma
    Image attribution tooltip
    Getty Images via Getty Images
    Image attribution tooltip

    Pharma’s capital allocation could shift as tariffs threaten an already fragile profit model

    Major changes to the dynamics of the pharmaceutical ecosystem are making executive decisions even tougher.

    By April 14, 2025
  • pharma manufacturing concept
    Image attribution tooltip
    Stock via Getty Images
    Image attribution tooltip

    Pharma’s US manufacturing moment: Where companies are making the biggest moves

    The tariff war has prompted new calls to reshore manufacturing. Several large pharmas have already made the leap.

    By April 11, 2025
  • President Donald Trump displays a chart showcasing coming tariff rates at the White House on April 2, 2025.
    Image attribution tooltip
    Chip Somodevilla via Getty Images
    Image attribution tooltip

    Trump’s tariff tirade and sudden calm keep Big Pharma on its toes

    A wild ride in an escalating trade war has torn at Big Pharma’s shares while global markets flag in the back-and-forth winds.

    By April 10, 2025
  • A person looks through a pipette while working at a laboratory bench.
    Image attribution tooltip
    Kevin Frayer via Getty Images
    Image attribution tooltip

    US risks losing biotech edge to China, report warns

    “There will be a ChatGPT moment for biotechnology,” a bipartisan commission wrote in the new report, which calls for the U.S. to invest at least $15 billion into the sector over the next five years.

    By Ned Pagliarulo • April 9, 2025
  • Contemporary artistic collage depicting hands holding binoculars against a blue background
    Image attribution tooltip
    Stock via Getty Images
    Image attribution tooltip

    Big Pharma is rewriting the R&D playbook to account for seismic shifts in the investment landscape

    The top 20 pharma companies are focusing on novel drugs, innovative dealmaking and playing to their strengths to bolster R&D ROI.

    By Alexandra Pecci • April 9, 2025
  • Vials of Eisai and Biogen's new Alzheimer's drug Leqembi
    Image attribution tooltip
    Courtesy of Eisai
    Image attribution tooltip

    US vs. EU: When it comes to novel Alzheimer’s drugs, regulators can’t seem to agree

    The FDA is much more flexible in approving first-in-class drugs compared to European regulators.  

    By April 7, 2025
  • robot hand pill
    Image attribution tooltip
    Stock via Getty Images
    Image attribution tooltip

    The year’s biggest biotech haul shows investors are still chasing the AI dream

    Isomorphic Labs recently raked in $600 million to help develop its drug discovery platform.

    By April 4, 2025
  • HHS staff cuts
    Image attribution tooltip
    Kevin Dietsch via Getty Images
    Image attribution tooltip
    Opinion

    Industry leaders react to HHS being ‘reduced to a shell’

    What healthcare watchdogs have said about the far-reaching job cuts this week.

    By Meagan Parrish and Amy Baxter • April 3, 2025
  • FDA
    Image attribution tooltip
    Sarah Silbiger via Getty Images
    Image attribution tooltip

    Is the FDA ‘finished’? Leadership drain hits agency hard.

    Amid widespread staff reductions at health agencies, a number of key officials have bid farewell to pharma’s top regulator.  

    By April 2, 2025
  • Mikael Dolsten, former CSO, Pfizer
    Image attribution tooltip
    Permission granted by Pfizer
    Image attribution tooltip
    Profile

    Former Pfizer CSO Mikael Dolsten on writing his next chapter, embracing AI and asking the ‘big questions’

    Dr. Mikael Dolsten, Pfizer’s former chief scientific officer, is embarking on a journey of curiosity and interconnectedness in his post-Big Pharma career.

    By April 1, 2025
  • megaphone quieted
    Image attribution tooltip
    Stock via Getty Images
    Image attribution tooltip

    With government health info in limbo, drugmakers lose credible sources

    The lack of clear communication from the government could spark wide-ranging issues in pharma — from sowing confusion about clinical trial design to further eroding public trust.

    By Alexandra Pecci • April 1, 2025
  • A sign reading Novo Nordisk is seen on the side of a building.
    Image attribution tooltip
    Victor Golmer via Getty Images
    Image attribution tooltip

    In the obesity triple-agonist blockbuster race, a familiar battle looms: Novo vs. Lilly

    The two market leaders are targeting new obesity alternatives in their pipelines with an eye toward a triple threat.  

    By March 31, 2025
  • fda logo
    Image attribution tooltip
    Stock via Getty Images
    Image attribution tooltip

    FDA’s ‘mixed signals’ on diversity have entangled clinical trials. Here’s how pharma can push ahead.

    The agency is still unclear about where it will stand on clinical trial diversity, but companies are looking for answers and leaning toward good science.

    By March 28, 2025
  • The HHS in DC
    Image attribution tooltip
    Alex Wong / Staff via Getty Images
    Image attribution tooltip

    HHS announces sweeping reorganization, including cuts of 10K workers

    Along with shrinking the HHS’ workforce further, the reorganization announced Thursday will cut the department from 28 divisions to 15, and close five regional offices.

    By Rebecca Pifer • March 27, 2025
  • 3D Illustration Concept of Human Respiratory System Lungs Anatomy
    Image attribution tooltip
    magicmine, iStock / Getty Images Plus via Getty Images
    Image attribution tooltip

    How AZ and Amgen’s Tezspire respiratory data ups the ‘level of ambition’ in immunology

    After Tezspire reduced the need for nasal polyp surgery by 98% in patients with a severe respiratory condition, the biopharma giants are even more ambitious for the next wave of biologic medicines.

    By March 27, 2025
  • Robert F. Kennedy Jr. stands in front of croded congressional room
    Image attribution tooltip
    Win McNamee via Getty Images
    Image attribution tooltip

    Rx-to-OTC rule gets pushed back — again

    A delay of the prescription-to-OTC rule signals health agencies’ ongoing reluctance to implement new regulations.

    By March 26, 2025
  • A sign with Biogen's logo sits outside the company's Cambridge, Massachusetts, headquarters on Sept. 5, 2024.
    Image attribution tooltip
    Jacob Bell/PharmaVoice
    Image attribution tooltip

    Biogen plots new global headquarters in Kendall Square

    The big biotech signed a 15-year lease for approximately 580,000-square-feet of space in “Kendall Commons,” a development project spearheaded by MIT.

    By Jacob Bell • March 25, 2025